Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.
2.

Tests of glycemia for the diagnosis of type 2 diabetes mellitus.

Barr RG, Nathan DM, Meigs JB, Singer DE.

Ann Intern Med. 2002 Aug 20;137(4):263-72. Review.

PMID:
12186517
3.

Screening for NIDDM in nonpregnant adults. A review of principles, screening tests, and recommendations.

Engelgau MM, Aubert RE, Thompson TJ, Herman WH.

Diabetes Care. 1995 Dec;18(12):1606-18. Review.

PMID:
8722060
4.

Screening for microalbuminuria to prevent nephropathy in patients with diabetes: a systematic review of the evidence.

Scheid DC, McCarthy LH, Lawler FH, Hamm RM, Reilly KE.

J Fam Pract. 2001 Aug;50(8):661-8. Review.

PMID:
11509158
5.

Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force.

Norris SL, Kansagara D, Bougatsos C, Fu R; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Jun 3;148(11):855-68. Review.

PMID:
18519931
6.

Screening for Type 2 diabetes--should it be now?

Borch-Johnsen K, Lauritzen T, Glümer C, Sandbaek A.

Diabet Med. 2003 Mar;20(3):175-81. Review.

PMID:
12675659
7.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
8.

[Screening and intervention. A strategy in type 2 diabetes?].

Jørgensen T, Glümer C, Borch-Johnsen K.

Ugeskr Laeger. 2002 Apr 15;164(16):2135-9. Review. Danish.

PMID:
11989055
9.
10.

[Screening for type 2 diabetes is justified].

Andersson DK, Petersson C.

Lakartidningen. 1998 Nov 11;95(46):5167-70, 5175. Review. Swedish.

PMID:
9842189
11.

[Screening in primary health care. How do the new criteria affect the incidence of diabetes?].

Andersson DK, Petersson C.

Lakartidningen. 1998 Nov 11;95(46):5171-5. Review. Swedish.

PMID:
9842190
12.

Screening for diabetes.

Backholer K, Chen L, Shaw J.

Pathology. 2012 Feb;44(2):110-4. doi: 10.1097/PAT.0b013e32834e8e12. Review.

PMID:
22228253
13.

What is the price of life and why doesn't it increase at the rate of inflation?

Ubel PA, Hirth RA, Chernew ME, Fendrick AM.

Arch Intern Med. 2003 Jul 28;163(14):1637-41. Review. No abstract available.

PMID:
12885677
14.

Review of glucose tolerance--a problem in methodology.

Duffy T, Phillips N, Pellegrin F.

Am J Med Sci. 1973 Feb;265(2):117-33. Review. No abstract available.

PMID:
4575432
15.

CT screening: a trade-off of risks, benefits, and costs.

Hunink MG, Gazelle GS.

J Clin Invest. 2003 Jun;111(11):1612-9. Review. No abstract available.

16.

Is screening for type 2 diabetes justified?

Davies MJ.

Practitioner. 1999 Feb;243(1595):93-4, 96, 98 passim. Review. No abstract available.

PMID:
10436603
17.

False positives and false negatives in genome scans.

Rao DC, Gu C.

Adv Genet. 2001;42:487-98. Review.

PMID:
11037337
18.

Uses and abuses of screening tests.

Grimes DA, Schulz KF.

Lancet. 2002 Mar 9;359(9309):881-4. Review. Erratum in: Lancet. 2008 Jun 14;371(9629):1998.

PMID:
11897304
19.
20.

Screening for type 2 diabetes: an update of the evidence.

Simmons RK, Echouffo-Tcheugui JB, Griffin SJ.

Diabetes Obes Metab. 2010 Oct;12(10):838-44. doi: 10.1111/j.1463-1326.2010.01244.x. Review.

PMID:
20920035

Supplemental Content

Support Center